Publications

Résultats 261 à 270 sur 560 Publications
Titre Auteurs
Chercheurs du CCNV* / Stagiaires du CCNV**
Année Revue
White matter degeneration – a treatable target?
Roseborough A**, Hachinski V*, Whitehead S* 2020 JAMA Neurology
Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β
Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Chamoun M, Savard M, Thomas E, Kang MS, Lussier F, Tissot C, Parsons M, Qureshi MNI, Vitali P, Massarweh G, Soucy JP, Rej S, Saha-Chaudhuri P, Gauthier S*, Rosa-Neto P* 2019 JAMA Neurology
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier FZ, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P*, Blennow K, Suárez-Calvet M, for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort 2021 JAMA Neurology
Frequency of loss of function variants in LRRK2 in Parkinson Disease Blauwendraat, C., Reed, X., Kia, D.A., Gan-Or, Z., Lesage, S., Pihlstrom, L., Guerreiro, R., Gibbs, J.R., Sabir M., Ahmed, S., Ding, J., Alcalay, R.N., Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease. Hassin-Baer, S., Pittma,n A.M., Brooks, J., Edsall, C., Hernandez, D.G., Chung, S.J., Goldwurm, S., Toft, M., Schulte, C., Bras, J., Wood, N.W., Brice, A., Morris, H.R., Scholz, S.W., Nalls, M.A., Singleton, A.B., Cookson, M.R., for the COURAGE-PD Consortium, the French Parkinson's Disease Consortium, & the International Parkinson's Disease Genomics Consortium. 2018 JAMA Neurology
Alzheimer Disease, biomarkers, and clinical symptoms – Quo Vadis?
Montero-Odasso M*, Ismail Z*, Camicioli R* 2020 JAMA Neurology
Association of dual-task gait with incident dementia in mild cognitive impairment: Results from the Gait and Brain Study Montero-Odasso, M. M., Sarquis-Adamson, Y., Speechley, M., Borrie, M. J., Hachinski, V. C., Wells, J., Riccio, P. M., Schapira, M., Sejdic, E., Camicioli, R., Bartha, R., McIlroy, W. E., & Muir-Hunter, S. 2017 JAMA Neurology
Dual-task gait and incident dementia-A step forward, but not there yet-reply Montero-Odasso, M., Camicioli, R., & Muir-Hunter, S.W. 2017 JAMA Neurology
Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment.
Montero-Odasso MM, Sarquis-Adamson Y, Speechley M, Borrie MJ, Hachinski VC, Wells J, Riccio PM, Schapira M, Sejdic E, Camicioli RM, Bartha R, McIlroy WE, Muir-Hunter S JAMA Neurology
Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial
Montero-Odasso, M.*, Zou, G.*, Speechley, M.*, Almeida, Q. J.*, Liu-Ambrose, T.*, Middleton, L. E.*, Camicioli, R.*, Bray, N. W.**, Li, K. Z. H.*, Fraser, S.*, Pieruccini-Faria, F.**, Berryman, N., Lussier, M.**, Shoemaker, J. K.*, Son, S.**, Bherer, L.*, & Canadian Gait and Cognition Network 2023 JAMA Network Open
Associations of Multidomain Interventions With Improvements in Cognition in Mild Cognitive Impairment: A Systematic Review and Meta-analysis
Salzman, T., Sarquis-Adamson, Y., Son, S., Montero-Odasso, M.*, & Fraser, S.*  2022 JAMA Network Open
Résultats 261 à 270 sur 560 Publications
Go back to top